Cite
MLA Citation
Yuji Piao et al.. “Novel MET/TIE2/VEGFR2 inhibitor altiratinib inhibits tumor growth and invasiveness in bevacizumab-resistant glioblastoma mouse models.” Neuro-oncology, vol. 18, no. 9, n.d., pp. 1230–1241. http://access.bl.uk/ark:/81055/vdc_100179398776.0x000011